Bluebird Ventures
Venture capitalPalo Alto · Seed–Series B · 1 people tracked
Also known as BLUEBIRD VENTURES GP I, LLC
Find your way into Bluebird Ventures
4,252 people in our graph share verified history with the Bluebird Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Bluebird Ventures backs early-stage life sciences companies, drawing on the founder's deep operating and investing experience in biotech, diagnostics, and therapeutics. The firm's activity centers on areas such as genomics, oncology, cancer detection, and novel therapies, reflecting its founder's track record investing in and building companies later acquired by major industry players.
Source: firm website, verified Sep 20, 2026.
Team · 1 people
from public directories
What they invest in
from 9 of 14 portfolio companiesBiotech ×8Healthtech ×6Medical Devices ×4AI & Machine Learning ×1Deep Tech ×1Fintech ×1SaaS ×1
HQs:United States×7United Kingdom×1Netherlands×1
Investments · 14 tracked
founders shown can be your intro pathBy year:2024 · 12022 · 22021 · 12020 · 12019 · 16 dated
GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear.
AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US
Jeffrey T. Huber(Director)Joshua Ofman, MD, MSHS(Chief Executive Officer)inAaron Freidin(Executive Officer)inJosh Ofman(Executive Officer)inRobert Ragusa(Executive Officer, Director)Jennifer Cook(Executive Officer, Director)in
PartnerJeffrey Bird· solo GP
Co-investorsAmino CapitalARCH Venture PartnersBezos ExpeditionsDecheng CapitalDentsu VenturesFelicis Ventures+8 more
-2.png)
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in
Co-investorsClavystBioF-Prime CapitalGV (Google Ventures)Casdin CapitalEuropean Innovation Council FundEuropean Investment Bank+6 more
Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy.
BiotechMedical DevicesSan Diego, US
Pam Taub(M.D., FACC, Founder)Alan Maisel(M.D., Founder)Francisco Villarreal(M.D., Ph.D., Founder)Jonathan Taub(Co-founder and first Chief Executive Officer)Guillermo Ceballos(M.D., Founding Scientist)Pam Taub, M.D., FACC(Co-founder)
PartnerJeffrey Bird· solo GP
Co-investorsBroadview VenturesLongitude CapitalAdams Street PartnersARCH Venture PartnersVertex VenturesVertex Ventures HC
Gilead discovers, develops, and delivers therapeutic medicines for life-threatening diseases, with focus on virology, oncology, and inflammation across 35+ countries.
BiotechHealthtechMedical DevicesPalo Alto, US
Ravindra Majeti(Director)Irving Weissman(Director)Eric Jensen(Executive Officer)
BoardChristopher Schaepe(Director)inJeffrey Bird(Director)inDennis Henner(Director)
PartnerJeffrey Bird· solo GP
Co-investorsLightspeed Venture PartnersSofinnova Ventures
Kriya provides working capital loans and business finance products to UK and European businesses, helping them manage cash flow, fund wholesale orders, and scale their buyer base.
FintechSaaS
Anil Stocker(Founder)in
Co-investorsMouro CapitalNorthzoneForesite CapitalJDRF T1D FundNarya CapitalPatient Square Capital+2 more
Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases.
BiotechHealthtechMorrisville, US
Shankar Ramaswamy(Co-Founder, Chairman & CEO)inRoger Jeffs(Co-Founder & Vice Chairman)inFraser Wright(Scientific Co-Founder & Chief Gene Therapy Officer)inShankar Ramaswamy, M.D.(Founder)inMichele Stone(Chief Scientific Officer)inKatherine Eade(Chief Legal Officer)
PartnerJeffrey Bird· solo GP
Co-investorsPatient Square CapitalPremji InvestAmplo VenturesForesite CapitalJDRF T1D FundNarya Capital+2 more
Medikine engineers cytokine mimetics — peptide-based therapeutics that mimic natural cytokines — to treat serious diseases, with a focus on immuno-oncology.
BiotechHealthtechSan Diego, US
William J. Dower(Co-founder and Scientific Advisor)Michael C. Needels(Co-founder and CTO)Ronald W. Barrett(CEO and Chairman of the Board)Joseph Leveque(CEO, President, and Board Member)in
PartnerJeffrey Bird· solo GP
RNA therapeutics company with a chip-based mRNA manufacturing platform; acquired by Medici Therapeutics in November 2025.
BiotechEmeryville, US
Igor Khandros(Executive Officer, Director)
PartnerJeffrey Bird· solo GP
Co-investors+ND CapitalARCH Venture PartnersSutter Hill Ventures
Procyrion develops medical devices for circulatory support in heart failure treatment, supported by a team of cardiologists and medical device industry veterans.
BiotechHealthtechMedical DevicesHouston, US
Reynolds, III M. Delagado(Director)Benjamin A. Hertzog(Executive Officer, Director)Dr. Fain(Founder/Executive)Jason J Heuring(Executive Officer)Bryan E. Nearn(Vice President)
BoardLeo III E Linbeck(Director)
PartnerJeffrey Bird· solo GP
Co-investorsScientific Health DevelopmentTexas VenturesFannin Goldenrod Holdings
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Epirium BioHelixPortola PharmaceuticalsTeneobioVerinata Health
Exits · 4
1 IPOs · 3 acquisitions · showing 3GRAILNASDAQ: GRALForty Seven Incacq. by GileadPortola Pharmaceuticalsacq. by Alexion
Portfolio news
latest coverage across their companies
GRAIL · simplywall.st · Jul 17, 2026
Leyden Labs · firstwordpharma.com · Jun 29, 2026
Kriya Therapeutics · nasdaqprivatemarket.com · Apr 3, 2026
Kriya · ophthalmologytimes.com · Dec 12, 2025
Epirium · endpoints.news · Jul 25, 2025
Nutcracker Therapeutics · businessmodelcanvastemplate.com · Jul 11, 2025
Frequently asked questions
- How many investments has Bluebird Ventures made?
- Bluebird Ventures has 14 tracked investments, 4 of which have exited.
- What stage does Bluebird Ventures invest at?
- Bluebird Ventures invests at the Seed, Series A, Series B stages.
- What sectors does Bluebird Ventures focus on?
- Bluebird Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Bluebird Ventures located?
- Bluebird Ventures is headquartered in Palo Alto, US.
- Who does Bluebird Ventures co-invest with?
- Bluebird Ventures most often shares deals with ARCH Venture Partners, Foresite Capital, Lightspeed Venture Partners, among 61 tracked co-investors.
Co-investors · 6
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Lightspeed is a global venture capital firm that has spent over two decades backing innovative companies as an early and first investor.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
Casdin Capital is an investment firm focused on the life sciences, investing across healthcare, biotechnology, synthetic biology, and related technology.
Maverick Capital is an investment management firm operating a unified platform of hedged and long strategies, serving both public and private investors since launching its first long/short equity fund in 1993.
Firms observed investing alongside Bluebird Ventures, from public investor directories. Shared companies are the overlap with Bluebird Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.